Small molecule-switchable RNA platform enables control of therapeutic protein expression

FHS
January 2, 2024
11:27 am

Just like a doctor adjusts the dose of a medication to the patient’s needs, the expression of therapeutic genes, those modified in a person to treat or cure a disease via gene therapy, also needs to be maintained within a therapeutic window.

Kidney disease therapy Jardiance gains FDA approval

Jardiance is intended to treat chronic kidney disease. Credit: Pixel-Shot / Shutterstock.com. Boehringer Ingelheim and Eli Lilly and Company have received approval from the US

September 25, 2023

Virtual driving assessments could forecast crash risk in young drivers

Virtual driving assessments at the time of licensure could predict crash risks in young drivers, potentially guiding targeted interventions to improve driving skills and safety.

October 18, 2023

Study demonstrates link between disrupted developmental dopamine signaling and ASD

Recent evidence suggests that dopamine plays a crucial role in neural development. In a novel study, investigators demonstrated the link between disrupted developmental dopamine signaling

May 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.